Brief: Regenxbio Announces Strategic Royalty Monetization Agreement For Up To $250 Million
19/05/2025 21:52
Regenxbio Inc RGNX.O: REGENXBIO ANNOUNCES STRATEGIC ROYALTY MONETIZATION AGREEMENT FOR UP TO $250 MILLION REGENXBIO ANNOUNCES STRATEGIC ROYALTY MONETIZATION AGREEMENT FOR UP TO $250 MILLION REGENXBIO INC - RECEIVES $150 MILLION, EXTENDS CASH RUNWAY TO 2027 Source text: ID:nPn6YRV3ha Further company coverage: RGNX.O
Recent news on REGENXBIO
See all newsBrief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics